Elmar Zurbriggen appointed as CEO of AOT, Peter Oprandi as CFO

We are excited to welcome two highly experienced managers to our team!

“Elmar and Peter have both gained decades of experience as senior managers in the life science sector, working for global market leaders such as Johnson & Johnson, Depuy Synthes, AstraZeneca and Lonza,” says Dr. Erich Platzer, Chairman of AOT’s Board of Directors. “We are delighted that they are now supporting AOT as CEO and CFO. Our goal is to improve patient care with innovative high-tech products. Elmar and Peter are exactly the right leaders for this.”

“I’m excited to work with a brilliant team of engineers and clinical specialists to further improve CARLO and make it available to patients around the world,” says Elmar Zurbriggen. CARLO is expected to receive FDA approval for the U.S. market as well as certification for other areas of application – such as orthopaedic surgery – within this year. Elmar Zurbriggen: “Laser is the future of bone surgery. Being able to help shape this future is extremely motivating.”

Peter Oprandi also meets his new role as CFO with enthusiasm: “CARLO is a true game changer that demonstrates how AOT’s patented technologies are advancing surgery. I am happy to be part of this success story and full of anticipation for the road ahead.”

About Elmar Zurbriggen

Elmar Zurbriggen is an internationally accomplished senior management professional with broad leadership experience in the life science industry (20 years medtech, 10 years biotech). He has excellent track records in areas such as international sales and marketing, strategy development and implementation, M&A integration and change management, product development, innovation and finance.

“I love to coach, help and support people, but also to reflect and create new ways of doing business. The most important thing for me is people who can live their passion in their work. If this works, success will set in by itself.”- Elmar Zurbriggen

About Peter Oprandi

Peter Oprandi has extensive international experience as a strategic finance and business leader with CDMOs, multinationals, start-ups and private equity. His activities in Europe, North and South America as well as Asia cover areas such as finance, audit, controlling, BD&L, supply chain, OE and operations. As part of his broad involvement in life sciences, he has been building effective partnerships between companies and investors for years.

“I am a goal-oriented, proactive leader and a business partner with a can-do attitude. A high level of integrity, strategic agility and entrepreneurial thinking sets me apart.” – Peter Oprandi

Further Links

Full Press Release about Elmar and Peter joining the team: